Literature DB >> 26250591

Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012.

Finja Jockenhöfer1, Joachim Klode1, Knut Kröger2, Alexander Roesch1, Philipp Al Ghazal3, Joachim Dissemond4.   

Abstract

Pyoderma gangrenosum (PG) is a rarely diagnosed non-infectious neutrophil ulcerative dermatosis with only limited knowledge on the underlying auto-inflammatory process. To unravel common cofactors and comorbidities in patients with PG we analysed Diagnosis Related Groups (DRG) cases of all inpatients diagnosed with PG in German hospitals in 2012. We received data of 1227 inpatient cases having PG as primary diagnosis and 985 inpatient cases with PG as secondary diagnosis. The ratio of women to men was 2:1, and the most often registered age was 75-79 years. Common comorbidities were arterial hypertension (50·3%), non-insulin-dependent diabetes mellitus (25·1%) and dysfunction of lipid metabolism (10·8%). In sum, 94·8% of the patients suffered from aspects of metabolic syndrome. Other comorbidities were Crohn's disease (4·5%), ulcerative colitis (4·2%), chronic polyarthritis (5·2%), monoclonal gammopathy or myelodysplastic syndrome (2·5%), leukaemia (1·1%) and lymphoma (0·4%). DRG data do not reflect individual patients, but rather patient cases. We described the worldwide largest PG population and confirmed a wide range of potentially relevant and partly not yet described cofactors and comorbidities such as metabolic syndrome.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic wounds; Comorbidities; German Federal Statistical Office; Metabolic syndrome; Pyoderma gangrenosum

Mesh:

Year:  2015        PMID: 26250591      PMCID: PMC7949574          DOI: 10.1111/iwj.12463

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  24 in total

Review 1.  Pyoderma gangrenosum: classification and management.

Authors:  F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

2.  Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.

Authors:  A M Binus; A A Qureshi; V W Li; L S Winterfield
Journal:  Br J Dermatol       Date:  2011-12       Impact factor: 9.302

Review 3.  Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions.

Authors:  M L Bennett; J M Jackson; J L Jorizzo; A B Fleischer; W L White; J P Callen
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

Review 4.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Authors:  D L Jacobson; S J Gange; N R Rose; N M Graham
Journal:  Clin Immunol Immunopathol       Date:  1997-09

5.  [Anthropometric data and obesity].

Authors:  K E Bergmann; G B Mensink
Journal:  Gesundheitswesen       Date:  1999-12

6.  The diagnosis and treatment of pyoderma gangraenosum.

Authors:  K Coady
Journal:  J Wound Care       Date:  2000-06       Impact factor: 2.072

Review 7.  Sex differences in autoimmune disease from a pathological perspective.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

8.  The evolution of pyoderma gangrenosum. A clinicopathologic correlation.

Authors:  R M Hurwitz; J H Haseman
Journal:  Am J Dermatopathol       Date:  1993-02       Impact factor: 1.533

Review 9.  ["TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept].

Authors:  U Müller-Ladner; R Alten; A Heiligenhaus; J Kekow; S Koletzko; U Mrowietz; T Ochsenkühn; M Radke; K Reich; M Rudwaleit; S Schreiber
Journal:  Dtsch Med Wochenschr       Date:  2009-10-06       Impact factor: 0.628

10.  Pyoderma gangrenosum: a review of 86 patients.

Authors:  F C Powell; A L Schroeter; W P Su; H O Perry
Journal:  Q J Med       Date:  1985-05
View more
  5 in total

Review 1.  [Brief review of the diagnostics of pyoderma gangraenosum].

Authors:  Joachim Dissemond
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.372

Review 2.  [Pyoderma gangrenosum].

Authors:  K Herberger
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

3.  Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study.

Authors:  Paola Monari; Ruggero Moro; Alberico Motolese; Cosimo Misciali; Carlotta Baraldi; Pier Alessandro Fanti; Stefano Caccavale; Mario Puviani; Daniela Olezzi; Pierfrancesco Zampieri; Giusto Trevisan; Katiuscia Nan; Chiara Fiorentini; Giovanni Pellacani; Giulio Gualdi
Journal:  Int Wound J       Date:  2018-06-06       Impact factor: 3.315

4.  Pyoderma Gangrenosum: A Retrospective Study of Clinical Charac-teristics, Comorbidities, Response to Treatment and Mortality Related to Prednisone Dose.

Authors:  Louise Schøsler; Karsten Fogh; Rikke Bech
Journal:  Acta Derm Venereol       Date:  2021-04-15       Impact factor: 3.875

5.  Negative Pressure Wound Therapy in Pyoderma Gangrenosum Treatment.

Authors:  Dariusz Bazaliński; Anna Karwiec; Marek Kucharzewski; Paweł Więch
Journal:  Am J Case Rep       Date:  2020-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.